Key result
Renal artery stenting normalizes blood pressure and eliminates all antihypertensive medications at 9 months.
Why the study?
Renal artery stenosis is a leading cause of secondary hypertension, with diagnostic challenges in identifying fibromuscular dysplasia-related stenosis.
Case Report (n=1)
No
A high index of clinical suspicion and thorough imaging evaluation can identify unusual cases of renal fibromuscular dysplasia, which can be successfully treated with covered stents to resolve secondary hypertension.
INTRODUCTION: Renal artery stenosis is a leading cause of secondary hypertension, with atherosclerosis and fibromuscular dysplasia as the main causes. CASE REPORT: A 41-year-old male developed progressive worsening of high blood pressure over the previous 5 years, along with erythrocytosis, despite compliance with dual antihypertensive therapy. Duplex ultrasound suggested the presence of a right renal artery stenosis. Subsequent tomography angiography (CTA) failed to report a significant stenosis. However, upon imaging reappraisal, the presence of a mid-section dilatation in the right renal artery was noted. Digital subtraction angiography confirmed the dilatation between 2 focal stenoses, which were not identifiable on CTA, suggestive of fibromuscular dysplasia. A translesional pressure gradient of 107mmHg107mmHg was determined. Renal artery stenting was performed with a 7×27mm7×27mm covered stent with good angiographic result. Nine months after intervention, blood pressure normalized, and antihypertensive medications were withdrawn. CONCLUSION: High clinical suspicion was key to adequately diagnose and manage this case of renovascular secondary hypertension.
No takes yet. Share an insight, caveat, or question.
Oliveira et al. (2026) conducted a case report in Secondary hypertension due to renal artery stenosis (fibromuscular dysplasia) (n=1). Renal artery stenting (covered stent) was evaluated on Blood pressure normalization. Renal artery stenting completely normalized blood pressure and allowed for the withdrawal of all antihypertensive medications at 9 months post-intervention.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: